Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.

Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.

Bibliographic Details
Main Authors:	Hale, G, Waldmann, H, Friend, P, Calne, R
Format:	Journal article
Language:	English
Published:	1986

Similar Items

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
by: Hale, G, et al.
Published: (1994)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
by: Waldmann, H, et al.
Published: (1985)

Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
by: Friend, P, et al.
Published: (1991)

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
by: Rebello, P, et al.
Published: (1999)

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
by: Waldmann, H, et al.
Published: (1985)

THE USE OF MONOCLONAL ANTILYMPHOCYTE ANTIBODIES IN CLINICAL IMMUNOSUPPRESSION
by: Friend, P, et al.
Published: (1985)

Specificity of monoclonal antibody Campath-1.
by: Hale, G, et al.
Published: (1988)

CAMPATH-1 FOLLOWING RENAL-TRANSPLANTATION - A RANDOMIZED TRIAL
by: Friend, P, et al.
Published: (1988)

Delayed allograft rejection in primates treated with anti-IL-2 receptor monoclonal antibody Campath-6.
by: Tighe, H, et al.
Published: (1988)

Availability of Campath-1 antibodies for bone marrow transplantation.
by: Hale, G, et al.
Published: (1995)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
by: Dyer, M, et al.
Published: (1988)

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.
by: Hale, G, et al.
Published: (1985)

Monoclonal antibodies for immunosuppression.
by: Waldmann, H, et al.
Published: (1988)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
by: Lim, S, et al.
Published: (1993)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
by: Isaacs, J, et al.
Published: (1996)

Campath-1M--prophylactic use after kidney transplantation. A randomized controlled clinical trial.
by: Friend, P, et al.
Published: (1989)

CAMPATH-1 antibodies in stem-cell transplantation.
by: Hale, G, et al.
Published: (2001)

REMISSION INDUCTION IN PATIENTS WITH LYMPHOID MALIGNANCIES USING UNCONJUGATED CAMPATH-1 MONOCLONAL-ANTIBODIES
by: Dyer, M, et al.
Published: (1990)

Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up.
by: Clatworthy, MR, et al.
Published: (2009)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
by: Naparstek, E, et al.
Published: (1999)

Campath 1H (alemtuzumab) in renal transplantation: 5-year comparative follow up.
by: Watson, C, et al.
Published: (2004)

Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.
by: Hale, G, et al.
Published: (1983)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
by: Isaacs, J, et al.
Published: (1995)

Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
by: Heit, W, et al.
Published: (1986)

Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trial.
by: Friend, P, et al.
Published: (1987)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
by: Naparstek, E, et al.
Published: (1993)

Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
by: Williams, R, et al.
Published: (2000)

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
by: Newman, D, et al.
Published: (1995)

Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.
by: Hale, G, et al.
Published: (1988)

CAMPATH-1H for the treatment of acute rejection in kidney transplant recipients: 10 year follow-up
by: Clatworthy, MR, et al.
Published: (2007)

Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen.
by: Xia, M, et al.
Published: (1993)

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
by: Watson, C, et al.
Published: (2005)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
by: Hale, G, et al.
Published: (1988)

Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using CAMPATH-I monoclonal antibody and E-rosetting.
by: Morgan, G, et al.
Published: (1986)

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.
by: Bindon, C, et al.
Published: (1988)

CAMPATH: from concept to clinic.
by: Waldmann, H, et al.
Published: (2005)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
by: Hale, G, et al.
Published: (1996)

ISOTYPE VARIANTS OF CAMPATH-1 ANTIBODY - REQUIREMENTS FOR EFFECTIVE ANTIBODY ACTION INVIVO
by: Dyer, M, et al.
Published: (1989)

T-cell depletion of stem cell grafts with campath-1H "in the bag" followed by cyclosporin immunosuppression remains a cost effective strategy in transplantation
by: Novitzky, N, et al.
Published: (2004)

COMPLEMENT LYSIS MEDIATED BY ENGINEERED MULTIPLE-DOMAIN FORMS OF THE THERAPEUTIC ANTIBODY CAMPATH-1H
by: Greenwood, J, et al.
Published: (1994)